A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The purpose of this study was to study the effect of different combinations of fenofibrate and metformin on the cluster of metabolic syndrome (MetS) biochemical abnormalities, and to determine the dose combination allowing normalization of MetS patients.
Epistemonikos ID: a0d22225b0a701a0ceb54aa573d9dd4c49ecdc23
First added on: May 05, 2024